Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001493152-25-022255·Ayrton Capital LLC
Schedule 13G ownership disclosure
CO-DIAGNOSTICS INC
Common Stock · CUSIP: 189763105
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Ayrton Capital LLC
Shares: 3,738,327.00 · Class: 9.70%
- Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B
Shares: 3,738,327.00 · Class: 9.70%
- Waqas Khatri
Shares: 3,738,327.00 · Class: 9.70%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-022255
- Form type
- SCHEDULE 13G
- Filer
- Ayrton Capital LLC
- CIK
- CIK 1698148
- Filed
- Nov 13, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership